Related Experiment Video

Updated: May 17, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Preventing and managing hyperglycemia in kidney transplant patients

Adnan Sharif1

  • 1Renal Institute of Birmingham, Queen Elizabeth Hospital, Birmingham, UK. sharif_adnan@hotmail.com

Current Opinion in Nephrology and Hypertension
|October 19, 2012
PubMed
Abstract

Insights

New onset diabetes after kidney transplantation (NODAT) is a common complication. Research is advancing understanding of risk factors and developing targeted prevention and management strategies for this distinct metabolic disorder.

Area of Science:

  • Nephrology
  • Endocrinology
  • Transplantation Medicine

Background:

  • New onset diabetes after kidney transplantation (NODAT) is a frequent complication, increasing morbidity and mortality in transplant recipients.
  • Understanding the unique pathophysiology of NODAT is crucial for effective clinical management.

Purpose of the Study:

  • To review recent advancements in understanding NODAT.
  • To explore emerging risk factors and therapeutic interventions for NODAT.
  • To discuss future directions in NODAT research and management.

Main Methods:

  • Literature review of recent studies on NODAT.
  • Analysis of risk factors, including pretransplant and posttransplant variables.
  • Examination of ongoing and published clinical trials on pharmacological interventions.

Main Results:

  • Identification of novel and existing risk factors contributing to NODAT development.
  • Variable success in developing quantitative risk scoring composites for NODAT.
  • Clinical trials exploring differential immunosuppression and antiglycemic agents for NODAT prevention and management are underway.

Conclusions:

  • NODAT is a distinct metabolic entity requiring specific investigation, not simply extrapolated from general diabetes data.
  • Targeted strategies are necessary for the effective prevention and management of NODAT.
  • Further research is essential to establish a robust evidence base for NODAT treatment.

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...